Financials Shenzhen New Industries Biomedical Engineering Co., Ltd.
Equities
300832
CNE100003T39
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.67 CNY | +2.63% |
|
+6.62% | -7.31% |
Projected Income Statement: Shenzhen New Industries Biomedical Engineering Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,195 | 2,545 | 3,047 | 3,930 | 4,535 | 5,160 | 6,205 | 7,107 |
| Change | - | 15.97% | 19.7% | 28.97% | 15.41% | 13.77% | 20.25% | 14.53% |
| EBITDA 1 | 1,190 | 1,248 | 1,479 | 1,928 | 2,178 | 2,445 | 2,972 | 3,361 |
| Change | - | 4.9% | 18.53% | 30.34% | 13% | 12.25% | 21.53% | 13.11% |
| EBIT 1 | 1,099 | 1,137 | 1,504 | 1,895 | 2,111 | 2,288 | 2,812 | 3,253 |
| Change | - | 3.54% | 32.19% | 26.06% | 11.38% | 8.38% | 22.91% | 15.66% |
| Interest Paid 1 | -26.24 | -29.09 | -0.2748 | -0.4342 | 34.75 | -35 | -41 | - |
| Earnings before Tax (EBT) 1 | 1,097 | 1,136 | 1,501 | 1,893 | 2,093 | 2,313 | 2,828 | 3,263 |
| Change | - | 3.53% | 32.2% | 26.1% | 10.57% | 10.49% | 22.29% | 15.38% |
| Net income 1 | 939.1 | 973.7 | 1,328 | 1,654 | 1,828 | 2,021 | 2,493 | 2,843 |
| Change | - | 3.68% | 36.38% | 24.53% | 10.57% | 10.54% | 23.36% | 14.01% |
| Announcement Date | 3/30/21 | 4/21/22 | 4/6/23 | 4/11/24 | 4/8/25 | - | - | - |
1CNY in Million
Estimates
Forecast Balance Sheet: Shenzhen New Industries Biomedical Engineering Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | -482 | -1,047 | -918 | -1,600 | -2,486 | -3,528 |
| Change | - | - | - | -117.22% | 12.32% | -74.26% | -55.38% | -41.91% |
| Announcement Date | 3/30/21 | 4/21/22 | 4/6/23 | 4/11/24 | 4/8/25 | - | - | - |
1CNY in Million
Estimates
Cash Flow Forecast: Shenzhen New Industries Biomedical Engineering Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 253 | 342.7 | 402.6 | 322.1 | 439.1 | 337.4 | 377.6 | 408.9 |
| Change | - | 35.43% | 17.47% | -19.98% | 36.32% | -23.17% | 11.92% | 8.29% |
| Free Cash Flow (FCF) 1 | - | - | 559.8 | 1,096 | 917.3 | 1,604 | 1,876 | 2,244 |
| Change | - | - | - | 95.81% | -16.31% | 74.85% | 16.93% | 19.62% |
| Announcement Date | 3/30/21 | 4/21/22 | 4/6/23 | 4/11/24 | 4/8/25 | - | - | - |
1CNY in Million
Estimates
Forecast Financial Ratios: Shenzhen New Industries Biomedical Engineering Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | 54.19% | 49.02% | 48.54% | 49.06% | 48.03% | 47.39% | 47.89% | 47.3% |
| EBIT Margin (%) | 50.05% | 44.69% | 49.35% | 48.23% | 46.55% | 44.34% | 45.32% | 45.77% |
| EBT Margin (%) | 49.97% | 44.61% | 49.27% | 48.17% | 46.15% | 44.82% | 45.58% | 45.92% |
| Net margin (%) | 42.79% | 38.25% | 43.58% | 42.08% | 40.32% | 39.17% | 40.18% | 40% |
| FCF margin (%) | - | - | 18.37% | 27.9% | 20.23% | 31.09% | 30.23% | 31.57% |
| FCF / Net Income (%) | - | - | 42.16% | 66.29% | 50.17% | 79.36% | 75.22% | 78.93% |
Profitability | ||||||||
| ROA | 21.43% | 17.02% | 18.93% | 20.31% | 20.5% | 19.37% | 20.52% | 20.7% |
| ROE | 22.44% | 18.85% | 21.89% | 23.72% | 22.85% | 21.66% | 22.77% | 23.05% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - | - | - | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 11.53% | 13.46% | 13.21% | 8.2% | 9.68% | 6.54% | 6.09% | 5.75% |
| CAPEX / EBITDA (%) | 21.27% | 27.46% | 27.22% | 16.71% | 20.16% | 13.8% | 12.71% | 12.16% |
| CAPEX / FCF (%) | - | - | 71.91% | 29.38% | 47.87% | 21.03% | 20.13% | 18.22% |
Items per share | ||||||||
| Cash flow per share 1 | 1.247 | 0.9829 | 1.224 | 1.805 | 1.726 | 2.452 | 3.01 | 3.409 |
| Change | - | -21.15% | 24.55% | 47.45% | -4.36% | 42.04% | 22.74% | 13.26% |
| Dividend per Share 1 | - | 0.6 | 0.7 | 1 | 1.3 | 1.388 | 1.603 | 1.851 |
| Change | - | - | 16.67% | 42.86% | 30% | 6.74% | 15.52% | 15.47% |
| Book Value Per Share 1 | 6.132 | 7.134 | 8.14 | 9.602 | 10.92 | 12.34 | 14.13 | 15.66 |
| Change | - | 16.34% | 14.11% | 17.95% | 13.68% | 13.08% | 14.5% | 10.83% |
| EPS 1 | 1.252 | 1.239 | 1.689 | 2.104 | 2.327 | 2.573 | 3.127 | 3.618 |
| Change | - | -1.03% | 36.32% | 24.61% | 10.59% | 10.56% | 21.53% | 15.71% |
| Nbr of stocks (in thousands) | 783,465 | 786,659 | 786,126 | 785,719 | 785,719 | 785,719 | 785,719 | 785,719 |
| Announcement Date | 3/30/21 | 4/21/22 | 4/6/23 | 4/11/24 | 4/8/25 | - | - | - |
1CNY
Estimates
| 2025 * | 2026 * | |
|---|---|---|
| P/E ratio | 25.5x | 21x |
| PBR | 5.32x | 4.65x |
| EV / Sales | 9.69x | 7.91x |
| Yield | 2.11% | 2.44% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
65.67CNY
Average target price
70.04CNY
Spread / Average Target
+6.66%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300832 Stock
- Financials Shenzhen New Industries Biomedical Engineering Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
